DEXILANT SOLUTAB Drug Patent Profile
✉ Email this page to a colleague
When do Dexilant Solutab patents expire, and when can generic versions of Dexilant Solutab launch?
Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.
This drug has one hundred and eleven patent family members in thirty-seven countries.
The generic ingredient in DEXILANT SOLUTAB is dexlansoprazole. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexilant Solutab
A generic version of DEXILANT SOLUTAB was approved as dexlansoprazole by PAR PHARM INC on April 19th, 2017.
Summary for DEXILANT SOLUTAB
International Patents: | 111 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Patent Applications: | 599 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DEXILANT SOLUTAB |
DailyMed Link: | DEXILANT SOLUTAB at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DEXILANT SOLUTAB
US Patents and Regulatory Information for DEXILANT SOLUTAB
DEXILANT SOLUTAB is protected by six US patents.
Patents protecting DEXILANT SOLUTAB
Multiple PPI dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Method for producing granules
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Method for producing granules
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Multiple PPI dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Orally-disintegrating solid preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEXILANT SOLUTAB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEXILANT SOLUTAB
See the table below for patents covering DEXILANT SOLUTAB around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Taiwan | I290922 | ⤷ Try a Trial | |
Japan | 3404648 | ⤷ Try a Trial | |
Australia | 5247800 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DEXILANT SOLUTAB
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1129088 | 1490004-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPRAZOL; REG. NO/DATE: 47912, 47913, 47914 20130919 |
1129088 | C01129088/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPARAZOL; REGISTRATION NO/DATE: SWISSMEDIC 62993 09.05.2014 |
1129088 | 122014000036 | Germany | ⤷ Try a Trial | PRODUCT NAME: KRISTALLINE FORM DES (R)-2-(((3-METHYL-4-(2,2,2-TRIFLUORETHOXY)-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAOLS; NAT. REGISTRATION NO/DATE: 87192.00.00 87193.00.00 87194.00.00 87195.00.00 20131118 FIRST REGISTRATION: SCHWEDEN 47911 47912 47913 47914 20130919 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |